1-18 of 18
John A. Foekens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy

Marjolein J.A. Weerts, Antoinette Hollestelle, Anieta M. Sieuwerts, John A. Foekens, Stefan Sleijfer, John W.M. Martens
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4735–4743.
https://doi.org/10.1158/1078-0432.CCR-17-0032
Published: 14 August 2017
View article titled, Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy
Open the PDF for Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract A15: High miRNA-26a and low EZH2 expression levels are associated with favorable outcome to tamoxifen in advanced breast cancer

Maurice P.H.M. Jansen, Esther A. Reijm, Anieta M. Sieuwerts, Kirsten Ruigrok-Ritstier, Frank Gerritse, Maxime P. Look, Marion E. Meijer-van Gelder, Marcel Smid, John W. Martens, Stefan Sleijfer, John A. Foekens, Els M.J.J. Berns
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A15.
https://doi.org/10.1158/1078-0432.TCME10-A15
Published: 02 February 2016
View article titled, Abstract A15: High miRNA-26a and low EZH2 expression levels are associated with favorable outcome to tamoxifen in advanced breast cancer
Journal Articles

Validation of a Radiosensitivity Molecular Signature in Breast Cancer

Steven A. Eschrich, William J. Fulp, Yudi Pawitan, John A. Foekens, Marcel Smid, John W.M. Martens, Michelle Echevarria, Vidya Kamath, Ji-Hyun Lee, Eleanor E. Harris, Jonas Bergh, Javier F. Torres-Roca
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (18): 5134–5143.
https://doi.org/10.1158/1078-0432.CCR-12-0891
Published: 16 September 2012
View article titled, Validation of a Radiosensitivity Molecular Signature in Breast Cancer
Open the PDF for Validation of a Radiosensitivity Molecular Signature in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients

Anieta M. Sieuwerts, Bianca Mostert, Joan Bolt-de Vries, Dieter Peeters, Felix E. de Jongh, Jacqueline M.L. Stouthard, Luc Y. Dirix, Peter A. van Dam, Anne Van Galen, Vanja de Weerd, Jaco Kraan, Petra van der Spoel, Raquel Ramírez-Moreno, Carolien H.M. van Deurzen, Marcel Smid, Jack X. Yu, John Jiang, Yixin Wang, Jan W. Gratama, Stefan Sleijfer, John A. Foekens, John W.M. Martens
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (11): 3600–3618.
https://doi.org/10.1158/1078-0432.CCR-11-0255
Published: 01 June 2011
View article titled, mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
Open the PDF for mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients

Bas Kreike, Hans Halfwerk, Nicola Armstrong, Peter Bult, John A. Foekens, Sanne C. Veltkamp, Dimitry S.A. Nuyten, Harry Bartelink, Marc J. van de Vijver
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (12): 4181–4190.
https://doi.org/10.1158/1078-0432.CCR-08-2644
Published: 15 June 2009
View article titled, Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients
Open the PDF for Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients in another window
Includes: Supplementary data
Journal Articles

DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy

Oliver Hartmann, Frédérique Spyratos, Nadia Harbeck, Dimo Dietrich, Anne Fassbender, Manfred Schmitt, Serenella Eppenberger-Castori, Vincent Vuaroqueaux, Florence Lerebours, Katrin Welzel, Sabine Maier, Achim Plum, Stephan Niemann, John A. Foekens, Ralf Lesche, John W.M. Martens
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 315–323.
https://doi.org/10.1158/1078-0432.CCR-08-0166
Published: 31 December 2008
View article titled, DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy
Open the PDF for DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response

Jozien Helleman, Maurice P.H.M. Jansen, Kirsten Ruigrok-Ritstier, Iris L. van Staveren, Maxime P. Look, Marion E. Meijer-van Gelder, Anieta M. Sieuwerts, Jan G.M. Klijn, Stefan Sleijfer, John A. Foekens, Els M.J.J. Berns
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5555–5564.
https://doi.org/10.1158/1078-0432.CCR-08-0555
Published: 02 September 2008
View article titled, Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response
Open the PDF for Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response in another window
Includes: Supplementary data
Journal Articles

Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer

Gert G. Van den Eynden, Marcel Smid, Steven J. Van Laere, Cecile G. Colpaert, Ilse Van der Auwera, Trinh Xuan Bich, Peter van Dam, Michael A. den Bakker, Luc Y. Dirix, Eric A. Van Marck, Peter B. Vermeulen, John A. Foekens
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 2944–2952.
https://doi.org/10.1158/1078-0432.CCR-07-4397
Published: 15 May 2008
View article titled, Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer
Open the PDF for Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

Christine Desmedt, Fanny Piette, Sherene Loi, Yixin Wang, Françoise Lallemand, Benjamin Haibe-Kains, Giuseppe Viale, Mauro Delorenzi, Yi Zhang, Mahasti Saghatchian d'Assignies, Jonas Bergh, Rosette Lidereau, Paul Ellis, Adrian L. Harris, Jan G.M. Klijn, John A. Foekens, Fatima Cardoso, Martine J. Piccart, Marc Buyse, Christos Sotiriou, on behalf of the TRANSBIG Consortium
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3207–3214.
https://doi.org/10.1158/1078-0432.CCR-06-2765
Published: 01 June 2007
View article titled, Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
Open the PDF for Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series in another window
Journal Articles

Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer

Anne-Sofie Schrohl, Marion E. Meijer-van Gelder, Mads N. Holten-Andersen, Ib Jarle Christensen, Maxime P. Look, Henning T. Mouridsen, Nils Brünner, John A. Foekens
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7054–7058.
https://doi.org/10.1158/1078-0432.CCR-06-0950
Published: 04 December 2006
View article titled, Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer
Open the PDF for Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer in another window
Journal Articles

Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients

Anieta M. Sieuwerts, Maxime P. Look, Marion E. Meijer-van Gelder, Mieke Timmermans, Anita M.A.C. Trapman, Roberto Rodriguez Garcia, Miranda Arnold, Anneke J.W. Goedheer, Vanja de Weerd, Henk Portengen, Jan G.M. Klijn, John A. Foekens
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3319–3328.
https://doi.org/10.1158/1078-0432.CCR-06-0225
Published: 01 June 2006
View article titled, Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients
Open the PDF for Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients in another window
Journal Articles

How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study

Anieta M. Sieuwerts, Marion E. Meijer-van Gelder, Mieke Timmermans, Anita M.A.C. Trapman, Roberto Rodriguez Garcia, Miranda Arnold, Anneke J.W. Goedheer, Henk Portengen, Jan G.M. Klijn, John A. Foekens
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (20): 7311–7321.
https://doi.org/10.1158/1078-0432.CCR-05-0560
Published: 20 October 2005
View article titled, How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study
Open the PDF for How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study in another window
Journal Articles

The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer

Lambert C. J. Dorssers, Nicolai Grebenchtchikov, Arend Brinkman, Maxime P. Look, Simone P. J. van Broekhoven, Danielle de Jong, Harry A. Peters, Henk Portengen, Marion E. Meijer-van Gelder, Jan G. M. Klijn, Doorlene T. H. van Tienoven, Anneke Geurts-Moespot, Paul N. Span, John A. Foekens, Fred C. G. J. Sweep
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (18): 6194–6202.
https://doi.org/10.1158/1078-0432.CCR-04-0444
Published: 24 September 2004
View article titled, The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer
Open the PDF for The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer in another window
Journal Articles

Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer

Anne-Sofie Schrohl, Mads N. Holten-Andersen, Harry A. Peters, Maxine P. Look, Marion E. Meijer-van Gelder, Jan G. M. Klijn, Nils Brünner, John A. Foekens
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (7): 2289–2298.
https://doi.org/10.1158/1078-0432.CCR-03-0360
Published: 08 April 2004
View article titled, Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer
Open the PDF for Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer in another window
Journal Articles

Vascular Endothelial Growth Factor Independently Predicts the Efficacy of Postoperative Radiotherapy in Node-Negative Breast Cancer Patients

Peggy Manders, Fred C. G. J. Sweep, Vivianne C. G. Tjan-Heijnen, Anneke Geurts-Moespot, Doorléne T. H. van Tienoven, John A. Foekens, Paul N. Span, Jan Bussink, Louk V. A. M. Beex
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (17): 6363–6370.
Published: 24 December 2003
View article titled, Vascular Endothelial Growth Factor Independently Predicts the Efficacy of Postoperative Radiotherapy in Node-Negative Breast Cancer Patients
Open the PDF for Vascular Endothelial Growth Factor Independently Predicts the Efficacy of Postoperative Radiotherapy in Node-Negative Breast Cancer Patients in another window
Journal Articles

Combined Vascular Endothelial Growth Factor and TP53 Status Predicts Poor Response to Tamoxifen Therapy in Estrogen Receptor-positive Advanced Breast Cancer

Els M. J. J. Berns, Jan G. M. Klijn, Maxime P. Look, Nicolai Grebenchtchikov, Rolf Vossen, Harry Peters, Anneke Geurts-Moespot, Henk Portengen, Iris L. van Staveren, Marion E. Meijer-van Gelder, Bert Bakker, Fred C. G. J. Sweep, John A. Foekens
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1253–1258.
Published: 01 April 2003
View article titled, Combined Vascular Endothelial Growth Factor and <em>TP53</em> Status Predicts Poor Response to Tamoxifen Therapy in Estrogen Receptor-positive Advanced Breast Cancer
Open the PDF for Combined Vascular Endothelial Growth Factor and <em>TP53</em> Status Predicts Poor Response to Tamoxifen Therapy in Estrogen Receptor-positive Advanced Breast Cancer in another window
Journal Articles

RNA Expression of Breast Cancer Resistance Protein, Lung Resistance-related Protein, Multidrug Resistance-associated Proteins 1 and 2, and Multidrug Resistance Gene 1 in Breast Cancer: Correlation with Chemotherapeutic Response

Herman Burger, John A. Foekens, Maxime P. Look, Marion E. Meijer-van Gelder, Jan G. M. Klijn, Erik A. C. Wiemer, Gerrit Stoter, Kees Nooter
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 827–836.
Published: 01 February 2003
View article titled, RNA Expression of Breast Cancer Resistance Protein, Lung Resistance-related Protein, Multidrug Resistance-associated Proteins 1 and 2, and Multidrug Resistance Gene 1 in Breast Cancer: <subtitle>Correlation with Chemotherapeutic Response</subtitle>
Open the PDF for RNA Expression of Breast Cancer Resistance Protein, Lung Resistance-related Protein, Multidrug Resistance-associated Proteins 1 and 2, and Multidrug Resistance Gene 1 in Breast Cancer: <subtitle>Correlation with Chemotherapeutic Response</subtitle> in another window
Journal Articles

Phase I and Pharmacological Study of the Oral Matrix Metalloproteinase Inhibitor, MMI270 (CGS27023A), in Patients with Advanced Solid Cancer

Nicola C. Levitt, Ferry A. L. M. Eskens, Ken J. O’Byrne, David J. Propper, Louis J. Denis, Samantha J. Owen, Les Choi, John A. Foekens, Sue Wilner, Jeanette M. Wood, Motowo Nakajima, Denis C. Talbot, William P. Steward, Adrian L. Harris, Jaap Verweij
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (7): 1912–1922.
Published: 01 July 2001
View article titled, Phase I and Pharmacological Study of the Oral Matrix Metalloproteinase Inhibitor, MMI270 (CGS27023A), in Patients with Advanced Solid Cancer
Open the PDF for Phase I and Pharmacological Study of the Oral Matrix Metalloproteinase Inhibitor, MMI270 (CGS27023A), in Patients with Advanced Solid Cancer in another window